A number of hypothesized factors including amyloid β (Aβ), hyperphosphorylated tau, cholinergic neuron damage and oxidative stress, inflammation, etc., were developed to explain AD pathological lesions and clinical symptoms. The gene discussed is MAPT; the disease is Alzheimer disease.